Most individuals infected with hepatitis C virus (HCV) develop progressive liver disease. A vaccine is urgently needed, and needs to mimic the immune responses seen in the minority of individuals who clear infection. However, there are large gaps in our understanding of these responses as most acute infections cause no illness and pass unnoticed. This project will fill these gaps by detailed immunological and virological analysis of a large group of subjects with early infection.
New Vectors, New Diseases: Understanding The Risk Of Chikungunya Transmission In Australia
Funder
National Health and Medical Research Council
Funding Amount
$522,580.00
Summary
Chikungunya is a febrile illness that can lead to chronic, debilitating joint pain in adults and severe neurological complications in children. Introductions of this virus into Australia have steadily increased in recent years. We will estimate the risk of chikungunya transmission in Australia now and into the future, and deliver the results to public health authorities to reduce the risk of outbreaks in Australia.